“I think the biggest problem in clinical trials is that they are underpowered. And that fundamentally, the studies are just too small.”

Anne Wojcicki is a Silicon Valley entrepreneur and philanthropist. She co-founded 23andMe, a company pioneering genetic testing and personalized health data, and later launched Verily, a life sciences research arm of Alphabet. Her work centers on merging technology with medicine to advance preventive healthcare and genetic research.